ABSTRACT
Long-term central venous catheterization is often required in cancer patients (frequently with poor peripheral access) for delivery of chemotherapy, blood and blood products, parenteral nutrition, fluids, and other medications. It has led to increased patient comfort as well as enhanced therapeutic options. However, despite many efforts to improve catheter biocompatibility, arm DVT remains a side-effect to be considered.
